{"id":"W4405922753","doi":"10.1002/ijc.35288","title":"Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the <scp>CLEAR</scp> trial","year":2024,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Eisai Canada; Eisai; Memorial Sloan-Kettering Cancer Center","keywords":"Lenvatinib; Pembrolizumab; Medicine; Sunitinib; Internal medicine; Renal cell carcinoma; Oncology; Post-hoc analysis; Cancer; Thyroid cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003961359,0.0008734455,0.002332489,0.0002982327,0.0002949571,0.0009442492,0.0007209435,0.0007662566,0.001808544],"category_scores_gemma":[0.002505406,0.000335298,0.003621352,0.0003013334,0.0006157659,0.0007537819,0.0004566869,0.002095646,0.0002633495],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008385786,"about_ca_system_score_gemma":0.001087383,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001002636,"about_ca_topic_score_gemma":0.00236765,"domain_scores_codex":[0.9977103,0.001501918,0.0001401894,0.0002553712,0.0001493789,0.0002426868],"domain_scores_gemma":[0.9976583,0.0009490871,0.0005062377,0.0001664478,0.0001255933,0.0005942909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9487756,0.00429739,0.02597244,0.00020023,0.006296819,0.00007352195,0.00007070591,0.001651607,0.003789807,0.00005372142,0.0009959305,0.007822204],"study_design_scores_gemma":[0.3036176,0.4315558,0.2422192,0.00005400588,0.008492478,0.0002190906,0.0002053365,0.006652873,0.004543646,0.0004213448,0.00192185,0.00009677555],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980629,0.0005898943,0.00009434313,0.00009679775,0.00005462495,0.0001673779,0.0005428342,0.000009286122,0.0003820642],"genre_scores_gemma":[0.9978689,0.000156615,0.0001728542,0.0001154893,0.00008447916,0.0002619301,0.0009688878,0.000005545325,0.0003653206],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003961359,"threshold_uncertainty_score":0.0209499,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02660081875484349,"score_gpt":0.3294860527871136,"score_spread":0.3028852340322701,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}